Next Article in Journal
Dual Molecular Design toward a Lysosome-Tagged AIEgen and Heavy-Atom-Free Photosensitizers for Hypoxic Cancer Photodynamic Therapy
Next Article in Special Issue
Exploratory Evaluation of EGFR-Targeted Anti-Tumor Drugs for Lung Cancer Based on Lung-on-a-Chip
Previous Article in Journal
Recent Advances in DNA Nanotechnology for Plasmonic Biosensor Construction
Previous Article in Special Issue
Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications

1
State Key Laboratory of Component-Based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
2
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
3
Tianjin Key Laboratory of Phytochemistry and Pharmaceutical Analysis, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China
*
Author to whom correspondence should be addressed.
Biosensors 2022, 12(6), 419; https://doi.org/10.3390/bios12060419
Submission received: 20 April 2022 / Revised: 30 May 2022 / Accepted: 13 June 2022 / Published: 15 June 2022
(This article belongs to the Special Issue Microfluidic Based Organ-on-Chips and Biomedical Application)

Abstract

:
Hydroxyapatite (HAP) materials are widely applied as biomedical materials due to their stable performance, low cost, good biocompatibility and biodegradability. Here, a green, fast and efficient strategy was designed to construct a fluorescent nanosystem for cell imaging and drug delivery based on polyethyleneimine (PEI) and functionalized HAP via simple physical adsorption. First, HAP nanorods were functionalized with riboflavin sodium phosphate (HE) to provide them with fluorescence properties based on ligand-exchange process. Next, PEI was attached on the surface of HE-functionalized HAP (HAP-HE@PEI) via electrostatic attraction. The fluorescent HAP-HE@PEI nanosystem could be rapidly taken up by NIH-3T3 fibroblast cells and successfully applied to for cell imaging. Additionally, doxorubicin hydrochloride (DOX) containing HAP-HE@PEI with high loading capacity was prepared, and in-vitro release results show that the maximum release of DOX at pH 5.4 (31.83%) was significantly higher than that at pH 7.2 (9.90%), which can be used as a drug delivery tool for cancer therapy. Finally, HAP-HE@PEI as the 3D inkjet printing ink were printed with GelMA hydrogel, showing a great biocompatible property for 3D cell culture of RAW 264.7 macrophage cells. Altogether, because of the enhanced affinity with the cell membrane of HAP-HE@PEI, this green, fast and efficient strategy may provide a prospective candidate for bio-imaging, drug delivery and bio-printing.

Graphical Abstract

1. Introduction

Multifunctional nanoparticles are of great interest for new applications such as cell imaging, drug delivery and tumor therapy [1,2,3,4,5]. Increasing surface chemistry strategies are used to establish these nanosystems via surface modification, such as polymer surface coating and small molecule surface grafting [6,7,8]. Among them, small molecule surface modification is one of the most commonly used methods, which has some advantages including fast and mild preparation process, excellent biocompatibility and superior fluorescence characteristics [9,10,11].
Hydroxyapatite (HAP) has attracted a great interest in biomedical fields due to its high stability, low cost, excellent biocompatibility and biodegradability [12,13,14,15]. The surface-functionalized HAP gives it many new properties, and the doping of rare earth ions is an efficient and typical surface modification to make it capable for cell imaging [16,17,18]. For example, He et al. successfully prepared Gd3+-doped monodisperse hydroxyapatite by hydrothermal method, which can be used for cell imaging in HeLa cells [19]. Hui et al. grafted an amphiphilic polymer with the hydrophobic end to the surface of a fluorinated Lu3+-doped HAP via hydrophobic interactions, which was successfully applied to cell imaging in A549 and Hela cells [20]. Zhou et al. completed the hydrophilic and hydrophobic transition by coating ethanolamine phosphate on the surface of nano-fluorine-doped HAP, and further coupled with quantum dots (QDs) to achieve the cell imaging in HepG2 and Hela cells [21]. However, rare earth materials are expensive and difficult to obtain, and the poor biocompatibility of QDs severely limits their application after modified with HAP. Therefore, the development of efficient and economical HAP surface modification methods is still urgently needed.
Riboflavin sodium phosphate (HE) is an inexpensive soluble small molecule with fabulous fluorescence properties, which has potential application prospects in the field of cell imaging. It has been reported that HE can be grafted on the surface of HAP through a single-ligand-exchange reaction to enable HAP acquire fluorescent properties [22]. However, the HE-grafted HAP may not be suitable for cell imaging because the HE molecules cannot enhance the HAP uptake by living cells. It is significant that nanoparticles for cell imaging mainly rely on the target uptake processes (i.e., endocytosis) by target cells [23,24,25]. Furthermore, with negative charge on the out-surface of the cell membrane, positively surface-charged nanoparticles can be attracted to the cells according to the principle of electrostatic interaction [26,27]. Thus, converting the surface charge of the nanoparticles into a positive charge is one of the effective ways to enhance their affinity with the cell membrane. Therefore, it is of great research significance to further develop rational modification methods to enhance the cell membrane affinity of HAP-HE.
Adsorption of a layer of cationic polymer on the surface of HAP-HE is an ideal modification to increase positive surface charge with the advantages of being green, mild and fast [28]. Polyethyleneimine (PEI) is a commonly used commercial cationic polymer with considerable adhesion properties. Thereby, modification of the cationic layer on the surface of HAP-HE can be easily achieved by using the PEI that has a strong adhesion ability.
Three-dimensional (3D) cell culture systems using cell scaffolds are currently under development. They not only better simulate the in vivo environment, but also have the advantages of intuition and controllability of cell culture. Application of 3D bio-printing strategies in these 3D models provides soluble gradients as the printing ink for cell patterning. However, it is still limited due to the lack of suitable materials for biological linkage [29]. Gel materials encapsulating live cells with good biocompatibility to form biological links are urgently required. To date, GelMA, deriving from a photoreactive gelatin derivative with the common arginyl-glycyl-aspartic acid (RGD) and matrix metalloproteinase (MMP) sequences, has shown promising advantages [30]. The introduction of GelMA during 3D bioprinting can both protect cells during extrusion and provide biological signals to embedded cells as the structures mature during culture [31]. Here, we initially explored the imaging effect of fluorescent nanomaterials (HAP-HE@PEI) on macrophage RAW264.7 cultured in GelMA.
In this study, we designed a fast, simple and mild establishment of multifunctional for the preparation of HAP-HE@PEI that is constructed by HE-modified HAP (HE-HAP) via a ligand exchange process to render it fluorescence property, and then wrapped PEI onto the surface of HE-HAP via electrostatic attraction to enhance cell membrane affinity of HE-HAP due to its high positive surface charge (Scheme 1). We further characterized encapsulation efficiency of doxorubicin (DOX) and pH-dependent release characteristics by HAP-HE@PEI. Moreover, we demonstrated the cell imaging capabilities of HAP-HE@PEI by showing its stable and high-intensity fluorescence accumulation in cytoplasm. This new HAP-HE@PEI nano-platform is expected to provide a promising system for cell imaging and drug delivery.

2. Materials and Methods

2.1. Materials

Hydroxyapatite (Mw: 502.31 Da, ≥97%, <100 nm particle size (BET)), riboflavin sodium phosphate (Mw: 478.33 Da, 93%), Polyethyleneimine (PEI, Mw: 1800 Da, 99%) and Doxorubicin hydrochloride (DOX, Mw: 579.98, 98%) were purchased from Aladdin (Shanghai, China). All the reagents were used directly without further purification.

2.2. Sample Characterization

The microscopic morphologies of the samples were obtained by transmission electron microscopy (TEM, JEOL2100, 200kV, JEOL, Japan). The hydrodynamic size and surface charge were examined by dynamic light scattering (DLS, Zetasizer Nano ZS90, Malvern, Malvern, UK). The crystal structures were investigated using X-ray diffraction (XRD, Rigaku D/MAX 2500V/PC, Rigaku, Japan). The elemental composition and changes were determined by X-ray photoelectron spectroscopy (XPS, Thermo Scientific Escalab 250Xi, Thermo Fisher, USA). Functional groups of the samples were analyzed by Fourier transform infrared spectrometer (FT-IR, Varian 640, Thermo Fisher, USA). The thermogravimetric information was obtained from thermogravimetric analyzer (TGA, TGA55, TA, USA). The fluorescence and UV spectra of the samples were recorded by fluorescence spectrometer (FL, HATICHI, F-7000, Hitachi, Japan) and UV-vis spectrophotometer (Cary 60, Agilent, USA), respectively. Cell imaging was implemented with the high-content imaging system (HCA system, PerkinElmer, Boston, MA, USA).

2.3. Preparation of HAP-HE

The HAP-HE was prepared by grafting HE onto the surface of HAP through ligand-exchange reaction [22]. In brief, 254 mg HAP and 72 mg HE were dispersed in 50 mL deionized water and then treated by ultrasonic for 10 min to form a uniform solution. Subsequently, the uniform solution was stirred, and the reaction lasted for 7 h at 60 °C. After that, the as-prepared product HAP-HE was separated by centrifugation (7500 rpm, 5 min), and then purified by centrifugation with deionized water 3 times. At last, samples were freeze-dried to obtain yellow HAP-HE powder.

2.4. Preparation of HAP-HE@PEI

HAP-HE@PEI was prepared by wrapping PEI on the surface of HAP-HE. Firstly, 20 mg HAP-HE was dispersed in 25 mL deionized water and stirred to make the dispersion uniform. Subsequently, 2 mL PEI was drawn with a syringe and slowly injected into the dispersion uniform, then stirred at room temperature for 3 h. Finally, the HAP-HE@PEI was obtained by vacuum drying after being purified by centrifugation with deionized water 3 times.

2.5. Encapsulation Efficiency and Release Characteristic of HAP-HE@PEI

Doxorubicin hydrochloride (DOX) was used as a test drug to evaluate the encapsulation efficiency of HAP-HE@PEI and to determine its release characteristic under different pH conditions in vitro. In short, 20 mg HAP-HE@PEI and 5 mg DOX were dispersed by ultrasonic in 50 mL phosphate buffer (PBS, pH 7.2), then stirred for 48 h in dark. After 48 h, the solid–liquid separation was achieved by centrifugation (rotational speed: 7500 rpm, 5 min), and the HAP-HE@PEI@DOX complex and supernatant were separated. The absorbance of the supernatant was measured by UV-Vis, and the encapsulation efficiency of HAP-HE@PEI with DOX was calculated according to the standard curve of DOX.
Y = ( l o a d e d   d r u g   q u a l i t y ) / ( T o t a l   d r u g   q u a l i t y ) × 100   %
According to the formula, the drug loading rate was calculated 83.3%. Then, the release characteristic of HAP-HE@PEI@DOX in PBS with different pH was tested in vitro. The process was as follows: Firstly, 3 mg HAP-HE@PEI@DOX was separately dispersed in the dialysis bag (Mw: 7000) with 2 mL PBS (pH 7.2). Then, the dialysis bag was bathed in a release system with 48 mL PBS in different pH (7.2 or 5.4) and stirred gently at 37 °C under dark conditions. At a preset time, 1 mL of liquid was removed from the release system and its absorbance was measured by UV-vis at a wavelength of 488 nm.

2.6. Cytotoxicity Evaluation

We used a CCK-8 kit to determine the effects of HAP-HE, HAP-HE@PEI, HAP-HE@PEI@DOX and free DOX on the survival rate of human lung cancer cell line A549. A549 cells were cultured in F-12K medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin and streptomycin and amplified at 37 °C and 5% CO2. In detail, A549 cells were inoculated in 96-well plates at a density of 8 × 103 per well and cultured for 24 h. Then the culture medium was removed and 100 μL HAP-HE, HAP-HE@PEI, HAP-HE@PEI@DOX, free DOX and DMEM (blank group) solution with different concentrations (0, 1, 10, 20, 40, 80 μg/mL) was added. After 24 h, the medium was removed and washed three times with PBS, then cells were incubated with 100 μL fresh culture medium containing 10 μL CCK-8 at 37 °C for 1.5 h. The absorbance was measured at 450 nm using a Microplate reader (SpectraMax@ i3).

2.7. High Content Cellular Imaging

The NIH-3T3 and A549 cell lines were utilized for high-content cellular imaging. NIH-3T3 cells were cultured in high glucose Dulbecco’s Modified Eagle’s Medium (DMEM) medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin and streptomycin and amplified at 37 °C, 5% CO2. A549 cells were cultured as described in 2.6. In detail, NIH-3T3 cells and A549 cells were seeded in 96-well blackboard at a density of 8 × 103 cells per well in 100 μL of the respective media containing 10% fetal bovine serum (FBS). After 24 h of cell attachment, NIH-3T3 and A549 cells were incubated with 12.5–100 μg/mL of HAP-HE or HAP-HE@PEI for preset time (0.5, 1, 3 h). Then, cells were washed 3 times with PBS to remove HAP-HE or HAP-HE@PEI that was not taken up by cells. After that, 50 μL of nucleation reagent Hoechst 33342 was added to each well and incubated in the dark for 30 min. Next, cells were washed three more times with PBS and 100 μL of PBS was re-added to the wells. Plates were then analyzed with HCA System. Three replicate wells were used for each control and test concentrations per well. The obtained fluorescence photos were processed with Image J software, and the results were processed with prism software. The results are presented as the mean ± standard deviation (SD).

2.8. HAP-HE@PEI for Cell Imaging of 3D Cultured Cells (Trial)

Macrophage RAW 264.7 cell line was used as a model cell to examine the cell imaging capabilities of HAP-HE@PEI under 3D culture conditions. Bioprinting ink composition: 1 mL 5 wt% GelMA (containing photo-initiator, 0.05 wt% LAP), 0.5 mL 0.02 wt% HAP-HE@PEI. RAW 264.7 cells were collected in the logarithmic growth phase, 1 mL of DMEM medium was added, and we pipetted evenly to obtain a uniformly distributed cell suspension. Then 1 mL of RAW 264.7 cell suspension (approximately 2 × 106 cells/mL) and 1 mL of GelMA containing HAP-HE@PEI were uniformly mixed in a 10 mL centrifuge tube for 30 s at room temperature for 3D-bioprinting (all operations are performed in a clean bench). The 3D inkjet bioprinter (CELLJET Cell Printer, CJ10009, America; dosing distance: 0.5 mm; value opening time: 1000 μs; value closing time: 1000 μs; air pressure: 60 Mpa) drawn 200 microliters of cell-containing bioprinting ink each time, and then printed the preset grid shape in a petri dish (20 × 20 mm) in a continuous printing manner. Subsequently, it was irradiated with UV light for 30 s and then we added high-glucose DMEM medium (containing 10% fetal bovine serum (FBS), 1% penicillin and streptomycin). RAW 264.7 macrophage cells were confined in solidified GelMA hydrogels and cultured at 37 °C, 5% CO2 with the medium renewed every 24 h. Fluorescence images were observed and obtained by Leica Microsystems CMS GmbH Ernst-Leitz-Str.17-37 (Leica, Germany).

3. Results

3.1. Morphological Characteristics of HAP and HAP-HE@PEI

The morphology features of HAP and HAP-HE@PEI composites were characterized by transmission electron microscope (TEM). A single HAP is a spindle-like, with dense and disordered pores of different sizes (Figure 1a). Compared with HAP, the morphology of HAP-HE@PEI did not change, but a high-contrast coating was observed on its surface (Figure 1b). Furthermore, the surface charges of HAP, HAP-HE, HAP-HE@PEI were measured by dynamic light scattering (DLS) technique. According to DLS data, their surface charge was −3.47, −13.87, 25.93 mV, respectively (Figure 1c).

3.2. Crystal Structure Comparison of HAP, HAP-HE, HAP-HE@PEI

The crystal structures of HAP, HAP-HE, HAP-HE@PEI were characterized by diffraction of X-rays (XRD). In the XRD pattern, HAP exhibits characteristic absorption peaks at 2θ of 25.8, 31.7, 39.8, 46.7, 49.4 and 53.1, respectively, and the strongest characteristic peak at 2θ of 31.7 (Figure 2). Compared with HAP, the XRD patterns of HAP-HE and HAP-HE@PEI had the same trend and the strongest characteristic peaks at the same position, which implied that both the high stability of HAP and the modification process did not change the crystal structure of HAP.

3.3. Element Contents and Changes of HAP, HAP-HE, HAP-HE@PEI

X-ray photoelectron spectroscopy (XPS) was used to analyze the chemical compositions of HAP, HAP-HE and HAP-HE@PEI. The survey of three samples demonstrate that all have the same elemental composition. The XPS spectrum of three samples shows three peaks at 132.0, 286.0, 352.0, 400.0, and 530.6 eV, which are attributed to P2p, C1s, Ca2p, N1s, and O1s, respectively (Figure 3a). The overall atomic percentage of elements present in HAP was carbon (15.78%), nitrogen (4.45%), oxygen (50.67%), calcium (16.26%) and phosphorus (12.84%) (Table S1). After the PEI modified on the surface of HAP-PE, the carbon element in HAP-HE@PEI increased from 15.78% to 51.67%; the nitrogen element increased from 4.45% to 18.18%; the oxygen element decreased from 50.67% to 19.35%, the calcium element decreased from 16.26% to 5.28% and the phosphorus element decreased from 12.84% to 5.21% (Figure 3b–f).

3.4. Fourier Transform Infrared Spectroscopy (FT-IR) Spectra of HAP, HAP-HE, HAP-HE@PEI

FT-IR spectra was used to further demonstrate the successful surface modification of HAP. At 3400, 1558, 1447, 1045, 848, 598 and 570 cm−1, HAP, HAP-HE and HAP-HE@PEI showed the same characteristic absorption peaks as HAP (Figure 4). Compared with HAP, the new characteristic peaks of benzene ring (1644–1454 cm−1) and C=O (1702 cm−1) emerged in the spectrum of HAP-HE. Moreover, after being modified with PEI, a new peak at 2900 cm−1 emerged, which could be attributed to -CH2-, and the absorption peak of C=O resulted in a blue-shift phenomenon compared with HAP-HE. In addition, FT-IR was also used to prove that the loading of DOX onto HAP-HE@PEI loaded DOX successfully (Figure S1). For that, DOX has strong characteristic absorption peaks at 3330, 2931, 1729, 1583, 1288 and 804 cm−1. Compared with DOX, a new characteristic peak of -O- (1045 cm−1) emerged and the intensity at 3330, 2931, 1729, 1583, 1288 and 804 cm−1 remarkably decreased in the spectrum of HAP-HE@PEI@DOX.

3.5. Thermogravimetric analysis of HAP, HAP-HE and HAP-HE@PEI

The thermogravimetric analyzer (TGA) was used to display the percentage of mass loss of the sample at different temperatures, thereby calculating the mass percentage of the grafted HE and PEI. First, in the range of 25–1000 °C, the mass of samples was all gradually decreased with the increasing test temperature (Figure 5). When the temperature reached 1000 °C, the remaining mass of HAP, HAP-HE and HAP-HE@PEI were 95.16%, 91.33% and 89.35%, respectively. Correspondingly, the weight loss of HAP, HAP-HE and HAP-HE@PEI was approximately 4.84%, 8.67% and 10.65%, respectively. By comparing the remaining masses of HAP and HAP-HE, the mass percentage of HE was approximately 3.83%. Furthermore, by comparing the remaining masses of HAP-HE and HAP-HE@PEI, the mass percentage of PEI was approximately 1.98%.

3.6. Fluorescence and UV Properties of HAP, HAP-HE and HAP-HE@PEI

Fluorescence spectroscopy (FL) and UV-Vis spectrum was used to analyze the fluorescence and ultraviolet characteristic of HAP, HAP-HE, HAP-HE@PEI, DOX and HAP-HE@PEI@DOX. Photographs of all samples in the UV light box were shown in Figure 6a. HAP does not have fluorescent properties, and it exhibits bright yellow-green fluorescence after grafting HE on the surface. Under 520 nm irradiation, HAP has no characteristic absorption, while HAP-HE shows stronger fluorescence absorption than HAP-HE@PEI (Figure 6b).
From the UV-Vis spectrum, HAP had no absorption whilst HE, HAP-HE and HAP-HE@PEI have absorption peaks at 374 and 448 nm (Figure 6c). Furthermore, under the excitation wavelength of 480 nm, HAP-HE@PEI (520 nm), HAP-HE@PEI@DOX (556 nm, 588 nm) and DOX (556 nm, 588 nm) produced features absorption (Figure S2a). The absorption peak intensity ratios of DOX and HAP-HE@PEI@DOX at 556 and 588 nm decreased from 2.83 (556 nm), 2.35 (588 nm) to 2.28 (556 nm), 1.05 (588 nm). On the other hand, HAP-HE@PEI@DOX and DOX exhibited characteristic absorptions with similar intensities at 480, 540 and 716 nm in the UV-Vis spectrum (Figure S2b).

3.7. Cytotoxicity Assay

Here, the A549 lung cancer cells were selected to test the cytotoxicity of HA-HE, HAP-HE@PEI, HAP-HE@PEI@DOX and DOX by CCK-8 assay. After 24 h co-incubation with A549 cells, the cell viability of HAP-HE and HAP-HE@PEI both exceeded 100% in the concentration range of 0–100 μg/mL (Figure S3). Subsequently, the cytotoxicity of HAP-HE@PEI@DOX and DOX was also tested by CCK-8 assay after co-incubation with A549 cells for 24 h. With the increasing concentration of HAP-HE@PEI@DOX and DOX, the cell viability was consistently decreased (Figure 7). When the incubated concentrations of HAP-HE@PEI@DOX and free DOX were higher than 10 μg/mL, HAP-HE@PEI@DOX and free DOX both had cell toxicity.

3.8. The Release Characteristic of HAP-HE@PEI@DOX at pH 7.2 and pH 5.4

We investigated the loading and release characteristic of DOX on HAP-HE@PEI to evaluate their potential for intracellular drug delivery. Firstly, based on UV-vis spectroscopy, we measured and calculated the loading of DOX on HAP-HE@PEI was 0.293 mg/mg. Afterwards, we further investigated the pH-responsive release of DOX from HAP-HE@PEI@DOX complexes at pH 5.4 and 7.2 (Figure 8). DOX was rapidly released from HAP-HE@PEI@DOX composites at pH 5.4 and 7.2 before the first 20 h (release rate, pH 5.4 > pH 7.2). The release rate of DOX gradually slowed down at pH 5.4 until it reached equilibrium after about 70 h; the release rate of DOX also gradually slowed down at pH 7.2, but reached equilibrium at about 48 h. Obviously, the maximum release of DOX at pH 5.4 (31.83%) was significantly higher than that at pH 7.2 (9.90%), indicating its applications for targeted cancer cell uptake and therapy.

3.9. Cell Imaging of 2D Cultured Cells

The high-content imaging system was used to obtain and analyze the fluorescence images after co-incubation of HAP-HE@PEI with NIH-3T3 fibroblast cells. The nuclei of NIH-3T3 cells are dotted by Hoechst 33342. Figure 9a showed the fluorescence results: it could be clearly observed that blue fluorescence only exists in the cytoplasm of NIH-3T3 cells. In addition, the fluorescence intensity of HAP-HE@PEI was proportional to its concentration after being taken up by NIH-3T3 cells, and had no significant relationship with the co-incubation time (Figure 9b,c). Among them, HAP-HE@PEI at 100 μg/mL after 3h incubation showed the highest fluorescence intensity. To prove that the surface-cationized HAP-HE@PEI can be taken up by cells more efficiently than HAP-HE, we further used A549 cells to collect their fluorescence images. Under the HAP-HE channel, even with 100 μg/mL and 3h incubation conditions, A549 cells cannot be marked effectively, and the background of green fluorescence was very strong (Figure S4), indicating HAP-HE@PEI has better imaging property than HAP-HE.

3.10. Cell Imaging of 3D Cultured Cells

We also prepared fluorescent HAP-HE@PEI mixed with GelMA hydrogel as 3D inkjet printing ink, after bio-printing with RAW 264.7 macrophage cells by CELLJET Cell Printer. Figure 10 showed the images observed under an inverted fluorescence microscope (blue filter: Ex = 488 nm), HAP-HE@PEI emitted green fluorescence and RAW 264.7 cells were confined in the GelMA hydrogel. RAW 264.7 cells had multiple cell clusters of different sizes in the hydrogel and grown in longitudinal aggregates, single cell presented a regular circle. These results demonstrated that HAP-HE@PEI is well tolerated by several types of cells.

4. Discussion

Good biocompatibility and high imaging efficiency are two necessary prerequisites for nanomaterial cellular imaging [32]. Although Hydroxyapatite (HAP) is widely used for cell imaging due to its good biocompatibility [33,34], its negative charge on the surface has insufficient affinity with the negatively charged cell membrane, resulting in low cell imaging efficiency [35,36]. Therefore, modifying HAP with positively charged compounds to achieve the conversion of HAP surface charge may be one effective strategy to improve the cell affinity. In our study, HAP-HE@PEI with high affinity for cell membranes was successfully prepared by coating the surface of HAP-HE with cationic polymer PEI. Firstly, we confirmed that the morphology of HAP-HE@PEI has no obvious change and the surface become positively charged compared with HAP by TEM and DLS. Then, we confirmed the good biocompatibility of HAP-HE@PEI through the CCK-8 test. In addition, the drug loading and in vitro release characteristic showed that HAP-HE@PEI had great loading capacity for DOX and HAP-HE@PEI@DOX exhibited pH responsiveness. High-content cellular imaging system demonstrated that HAP-HE@PEI had excellent cellular imaging capability. Our results demonstrated that HAP-HE@PEI could be considered as a candidate vehicle for cancer cell imaging and drug delivery at the same time.
Although TEM results suggest that there is no obvious difference in morphology between HAP and HAP in HAP-HE@PEI, more precise data are still needed to prove whether the crystal structure of HAP has changed before and after modification. XRD results showed that the ligand exchange reaction on the surface of HE-grafted HAP and the encapsulation of HAP-HE by PEI were mild, and did not affect the crystal structure of HAP [37].
We also consider the reason for the differential release rate under pH 5.4 and pH 7.2 conditions. The hydrogen ion concentration in PBS solution at pH 5.4 is higher than that in PBS solution at pH 7.2. Due to the dissociation effect of hydrogen ions on HAP-HE@PEI, HAP-HE@PEI@DOX formed a huge concentration difference inside and outside the dialysis bag. Meanwhile, the diffusion behavior of DOX in the dialysis bag might be similarly caused by the concentration difference formed by HAP-HE@PEI@DOX [38].
Finally, to explore the cell imaging potential of HAP-HE@PEI for 3D cultured cells in hydrogels, we chose GelMA as the experimental biomaterial due to its excellent biocompatibility providing cell adhesion sites, supporting cells and allowing nutrients to diffuse [39]. Possible reasons for the different size of cell clusters in the 3D cultured model may be the uneven distribution of cells during the printing process, or the aggregation of cells after printing. In addition, the rigid force that can induce RAW 264.7 cells polarize into other phenotypes exist in the 2D culture environment, but not in the 3D culture environment [40]. The accumulation of green fluorescence in the cell mass was caused by the active uptake of HAP-HE@PEI in GelMA by RAW 264.7 cells. Moreover, the sporadic green circular patterns may be the fluorescence from proliferating cells after uptake of HAP-HE@PEI. Our results show that HAP-HE@PEI has promising imaging potential for RAW 264.7 cells under 3D culture conditions. Based on these findings, we plan to use HAP-HE@PEI with different concentration gradients to eliminate the background fluorescence generated in the 3D environment in future. In addition, as a fluorescent doped material, HAP-HE@PEI may also have application potential for bone repair and bone fluorescent tracing [41]. After reducing the size of HAP (whiskers are about 5 nm), HAP-HE@PEI can also be used as a dopant material in microfluidic chips or as a fluorescent marker to quantify the proliferation of cells in the chip [34,42]. Altogether, combining the advantages of fabrication methods and HAP-HE@PEI, this work thus allows for quick and efficient imaging and drug delivery and is expected to have many in-vitro, ex-vivo and in-vivo applications.

5. Conclusions

In summary, we reported a facile and efficient strategy for the fabrication of cationic polymer-functionalized HAP via physical encapsulation. The strategy is based on physical encapsulation (charge attraction), which is simple, fast, efficient and could occur under rather mild conditions (e.g., air, water, catalyst-free, room temperature). After the introduction of PEI, HAP-HE@PEI demonstrated an outstanding cell membrane affinity and good biocompatibility. The HAP-HE@PEI has high encapsulation efficiency and release characteristic with the ability of pH responsiveness. Moreover, high-content imaging analysis shows that HAP-HE@PEI has high biocompatibility, rapid cellular uptake and satisfactory cell imaging ability. Finally, our initial exploration shows that HAP-HE@PEI still has good cell imaging ability under 3D culture conditions. Combining the advantages of fabrication methods and HAP-HE@PEI, this work has implications for biomaterial development aiming methods to improve the efficiency of cellular imaging.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/bios12060419/s1, Figure S1: Normalized FT-IR spectra of DOX and HAP-HE@PEI@DOX samples; Figure S2: Fluorescence and UV-vis spectra of HAP-HE@PEI@DOX and DOX. (a) FL Spectrum (Excitation wavelength: 480 nm); (b) UV-Vis Spectrum; Figure S3: Determination of cell viability of HAP-HE, HAP-HE@PEI with equal concentration gradient. The cell survival viability of A549 cells co-incubated with gradient mass concentration of HAP-HE and HAP-HE@PEI for 24 h; Figure S4: High-content imaging images of A549 cells co-incubated with 100 μg/mL of HAP-HE for 3h (HAP-HE@PEI: Ex= 440 nm, Em= 520 nm; Hochest 33342 for nucleus: Ex= 346 nm, Em= 460 nm); Table S1: The percentage of each element of HAP, HAP-HE and HAP-HE@PEI.

Author Contributions

Conceptualization, J.Y. and W.W.; methodology, W.W. and Z.L.; software, W.W.; validation, J.Y., W.W. and X.W.; formal analysis, J.Y. and W.W.; investigation, J.Y. and W.W.; resources, J.Y. and F.T.; data curation, J.Y., W.W. and Z.L.; writing—original draft preparation, W.W., Z.L., X.W. and J.Y.; writing—review and editing, J.Y. and W.W.; visualization, J.Y. and W.W.; supervision, J.Y. and F.T.; project administration, J.Y.; funding acquisition, J.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Key R&D Program of China (No. 2020YFA0708000), National Natural Science Foundation of China (No. 82074032) and Science and Technology Program of Tianjin (21ZYJDJC00070).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Yan Zhu is gratefully acknowledged for fruitful discussions and paper modifications.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Chen, X.; Guo, Q.; Chen, W.; Xie, W.; Wang, Y.; Wang, M.; You, T.; Pan, G. Biomimetic design of photonic materials for biomedical applications. Acta Biomater. 2021, 121, 143–179. [Google Scholar] [CrossRef] [PubMed]
  2. Broadwater, D.; Medeiros, H.C.; Lunt, R.R.; Lunt, S.Y. Current Advances in Photoactive Agents for Cancer Imaging and Therapy. Annu. Rev. Biomed. Eng. 2021, 23, 29–60. [Google Scholar] [CrossRef] [PubMed]
  3. Yodsanit, N.; Wang, B.; Zhao, Y.; Guo, L.W.; Kent, K.C.; Gong, S. Recent progress on nanoparticles for targeted aneurysm treatment and imaging. Biomaterials 2021, 265, 120406. [Google Scholar] [CrossRef] [PubMed]
  4. Song, N.; Zhang, J.; Zhai, J.; Hong, J.; Yuan, C.; Liang, M. Ferritin: A Multifunctional Nanoplatform for Biological Detection, Imaging Diagnosis, and Drug Delivery. Acc. Chem. Res. 2021, 54, 3313–3325. [Google Scholar] [CrossRef] [PubMed]
  5. Wong, X.Y.; Sena-Torralba, A.; Alvarez-Diduk, R.; Muthoosamy, K.; Merkoçi, A. Nanomaterials for Nanotheranostics: Tuning Their Properties According to Disease Needs. ACS Nano 2020, 14, 2585–2627. [Google Scholar] [CrossRef]
  6. Akhlaghi, S.P.; Berry, R.C.; Tam, K.C.J.C. Nanocelluloses as a Novel Vehicle for Controlled Drug Delivery. In Handbook of Nanocelluloses; Springer International Publishing: Cham, Switzerland, 2013; pp. 1747–1764. [Google Scholar]
  7. Bazaka, K.; Jacob, M.V.; Crawford, R.J.; Ivanova, E.P. Plasma-assisted surface modification of organic biopolymers to prevent bacterial attachment. Acta Biomater. 2011, 7, 2015–2028. [Google Scholar] [CrossRef]
  8. Ebrahimi, S.B.; Samanta, D.; Mirkin, C.A. DNA-Based Nanostructures for Live-Cell Analysis. J. Am. Chem. Soc. 2020, 142, 11343–11356. [Google Scholar] [CrossRef]
  9. Rauschenbach, M.; Lawrenson, S.B.; Taresco, V.; Pearce, A.K.; O’Reilly, R.K. Antimicrobial Hyperbranched Polymer-Usnic Acid Complexes through a Combined ROP-RAFT Strategy. Macromol. Rapid Commun. 2020, 41, e2000190. [Google Scholar] [CrossRef]
  10. Christopherson, C.J.; Paisley, N.R.; Xiao, Z.; Algar, W.R.; Hudson, Z.M. Red-Emissive Cell-Penetrating Polymer Dots Exhibiting Thermally Activated Delayed Fluorescence for Cellular Imaging. J. Am. Chem. Soc. 2021, 143, 13342–13349. [Google Scholar] [CrossRef]
  11. Wang, Y.P.; Wu, K.; Pan, M.; Li, K.; Mo, J.T.; Duan, X.H.; He, H.Z.; Shen, J.; Su, C.Y. One-/Two-Photon Excited Cell Membrane Imaging and Tracking by a Photoactive Nanocage. ACS Appl. Mater. Interfaces 2020, 12, 35873–35881. [Google Scholar] [CrossRef]
  12. Ji, X.; Yuan, X.; Ma, L.; Bi, B.; Zhu, H.; Lei, Z.; Liu, W.; Pu, H.; Jiang, J.; Jiang, X.; et al. Mesenchymal stem cell-loaded thermosensitive hydroxypropyl chitin hydrogel combined with a three-dimensional-printed poly(ε-caprolactone)/nano-hydroxyapatite scaffold to repair bone defects via osteogenesis, angiogenesis and immunomodulation. Theranostics 2020, 10, 725–740. [Google Scholar] [CrossRef] [PubMed]
  13. Deng, L.; Li, Y.; Zhang, A.; Zhang, H. Nano-hydroxyapatite incorporated gelatin/zein nanofibrous membranes: Fabrication, characterization and copper adsorption. Int. J. Biol. Macromol. 2020, 154, 1478–1489. [Google Scholar] [CrossRef] [PubMed]
  14. Gan, S.; Lin, W.; Zou, Y.; Xu, B.; Zhang, X.; Zhao, J.; Rong, J. Nano-hydroxyapatite enhanced double network hydrogels with excellent mechanical properties for potential application in cartilage repair. Carbohydr. Polym. 2020, 229, 115523. [Google Scholar] [CrossRef] [PubMed]
  15. Lara-Ochoa, S.; Ortega-Lara, W.; Guerrero-Beltrán, C.E. Hydroxyapatite Nanoparticles in Drug Delivery: Physicochemistry and Applications. Pharmaceutics 2021, 13, 1642. [Google Scholar] [CrossRef]
  16. El-Maghrabi, H.H.; Younes, A.A.; Salem, A.R.; Rabie, K.; El-Shereafy, E.S. Magnetically modified hydroxyapatite nanoparticles for the removal of uranium (VI): Preparation, characterization and adsorption optimization. J. Hazard. Mater. 2019, 378, 120703. [Google Scholar] [CrossRef]
  17. Li, D.; Huang, X.; Wu, Y.; Li, J.; Cheng, W.; He, J.; Tian, H.; Huang, Y. Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug. Biomater. Sci. 2016, 4, 272–280. [Google Scholar] [CrossRef]
  18. Ma, B.; Zhang, S.; Qiu, J.; Li, J.; Sang, Y.; Xia, H.; Jiang, H.; Claverie, J.; Liu, H. Eu/Tb codoped spindle-shaped fluorinated hydroxyapatite nanoparticles for dual-color cell imaging. Nanoscale 2016, 8, 11580–11587. [Google Scholar] [CrossRef]
  19. He, Y.; Lv, C.; Hou, X.; Wu, L. Mono-dispersed nano-hydroxyapatite based MRI probe with tetrahedral DNA nanostructures modification for in vitro tumor cell imaging. Anal. Chim. Acta 2020, 1138, 141–149. [Google Scholar] [CrossRef]
  20. Hui, J.; Zhang, X.; Zhang, Z.; Wang, S.; Tao, L.; Wei, Y.; Wang, X. Fluoridated HAp: Ln3+ (Ln = Eu or Tb) nanoparticles for cell-imaging. Nanoscale 2012, 4, 6967–6970. [Google Scholar] [CrossRef]
  21. Zhou, R.; Li, M.; Wang, S.; Wu, P.; Wu, L.; Hou, X. Low-toxic Mn-doped ZnSe@ZnS quantum dots conjugated with nano-hydroxyapatite for cell imaging. Nanoscale 2014, 6, 14319–14325. [Google Scholar] [CrossRef]
  22. Heng, C.; Zheng, X.; Liu, M.; Xu, D.; Huang, H.; Deng, F.; Hui, J.; Zhang, X.; Wei, Y. Fabrication of Luminescent Hydroxyapatite Nanorods through Surface-initiated RAFT. Appl. Surf. Sci. 2016, 386, 269–275. [Google Scholar] [CrossRef] [Green Version]
  23. Khan, I.; Steeg, P.S. Endocytosis: A pivotal pathway for regulating metastasis. Br. J. Cancer 2021, 124, 66–75. [Google Scholar] [CrossRef] [PubMed]
  24. Ju, Y.; Guo, H.; Edman, M.; Hamm-Alvarez, S.F. Application of advances in endocytosis and membrane trafficking to drug delivery. Adv. Drug Deliv. Rev. 2020, 157, 118–141. [Google Scholar] [CrossRef] [PubMed]
  25. Joshi, B.S.; de Beer, M.A.; Giepmans, B.N.; Zuhorn, I.S. Endocytosis of Extracellular Vesicles and Release of Their Cargo from Endosomes. ACS Nano 2020, 14, 4444–4455. [Google Scholar] [CrossRef] [Green Version]
  26. Liu, Z.; Wang, F.; Liu, X.; Sang, Y.; Zhang, L.; Ren, J.; Qu, X. Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo. Proc. Natl. Acad. Sci. USA 2021, 118, e2022769118. [Google Scholar] [CrossRef]
  27. Fontana, F.; Lindstedt, H.; Correia, A.; Chiaro, J.; Kari, O.K.; Ndika, J.; Alenius, H.; Buck, J.; Sieber, S.; Mäkilä, E.; et al. Influence of Cell Membrane Wrapping on the Cell-Porous Silicon Nanoparticle Interactions. Adv. Healthc. Mater. 2020, 9, e2000529. [Google Scholar] [CrossRef]
  28. Zhang, Y.; Huang, Z.; Ruan, B.; Zhang, X.; Jiang, T.; Ma, N.; Tsai, F.C. Design and Synthesis of Polyimide Covalent Organic Frameworks. Macromol. Rapid Commun. 2020, 41, e2000402. [Google Scholar] [CrossRef]
  29. Alphandéry, E. Light-Interacting iron-based nanomaterials for localized cancer detection and treatment. Acta Biomater. 2021, 124, 50–71. [Google Scholar] [CrossRef]
  30. Kurian, A.G.; Singh, R.K.; Patel, K.D.; Lee, J.H.; Kim, H.W. Multifunctional GelMA platforms with nanomaterials for advanced tissue therapeutics. Bioact. Mater. 2021, 8, 267–295. [Google Scholar] [CrossRef]
  31. Hwangbo, H.; Lee, H.; Jin, E.J.; Lee, J.; Jo, Y.; Ryu, D.; Kim, G. Bio-printing of aligned GelMa-based cell-laden structure for muscle tissue regeneration. Bioact. Mater. 2021, 8, 57–70. [Google Scholar] [CrossRef]
  32. Santos, O.; Cancino-Bernardi, J.; Pincela Lins, P.M.; Sampaio, D.; Pavan, T.; Zucolotto, V. Near-Infrared Photoactive Theragnostic Gold Nanoflowers for Photoacoustic Imaging and Hyperthermia. ACS Appl. Bio Mater. 2021, 4, 6780–6790. [Google Scholar] [CrossRef]
  33. Biedrzycka, A.; Skwarek, E.; Hanna, U.M. Hydroxyapatite with magnetic core: Synthesis methods, properties, adsorption and medical applications. Adv. Colloid. Interface Sci. 2021, 291, 102401. [Google Scholar] [CrossRef] [PubMed]
  34. Awasthi, S.; Pandey, S.K.; Arunan, E.; Srivastava, C. A review on hydroxyapatite coatings for the biomedical applications: Experimental and theoretical perspectives. J. Mater. Chem. B 2021, 9, 228–249. [Google Scholar] [CrossRef] [PubMed]
  35. Chen, F.; He, J.; Manandhar, P.; Yang, Y.; Liu, P.; Gu, N. Gauging surface charge distribution of live cell membrane by ionic current change using scanning ion conductance microscopy. Nanoscale 2021, 13, 19973–19984. [Google Scholar] [CrossRef] [PubMed]
  36. Ramirez, P.; Cervera, J.; Ali, M.; Nasir, S.; Ensinger, W.; Mafe, S. Impact of Surface Charge Directionality on Membrane Potential in Multi-ionic Systems. J. Phys. Chem. Lett. 2020, 11, 2530–2534. [Google Scholar] [CrossRef] [PubMed]
  37. Dai, L.L.; Nudelman, F.; Chu, C.H.; Lo, E.C.; Mei, M.L. The effects of strontium-doped bioactive glass and fluoride on hydroxyapatite crystallization. J. Dent. 2021, 105, 103581. [Google Scholar] [CrossRef]
  38. Ullah, M.; Kodam, S.P.; Mu, Q.; Akbar, A. Microbubbles versus extracellular vesicles as therapeutic cargo for targeting drug delivery. ACS Nano 2021, 15, 3612–3620. [Google Scholar] [CrossRef]
  39. Nichol, J.W.; Koshy, S.T.; Bae, H.; Hwang, C.M.; Yamanlar, S.; Khademhosseini, A. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 2010, 31, 5536–5544. [Google Scholar] [CrossRef] [Green Version]
  40. Doctor, A.; Seifert, V.; Ullrich, M.; Hauser, S.; Pietzsch, J. Three-Dimensional Cell Culture Systems in Radiopharmaceutical Cancer Research. Cancers 2020, 12, 2765. [Google Scholar] [CrossRef]
  41. Dimitriou, R.; Jones, E.; McGonagle, D.; Giannoudis, P.V. Bone regeneration: Current concepts and future directions. BMC Med. 2011, 9, 66. [Google Scholar] [CrossRef] [Green Version]
  42. Ding, S.; Zhang, H.; Wang, X. Microfluidic-Chip-Integrated Biosensors for Lung Disease Models. Biosensors 2021, 11, 456. [Google Scholar] [CrossRef] [PubMed]
Scheme 1. Preparation process of HAP-HE@PEI with positively charged surface.
Scheme 1. Preparation process of HAP-HE@PEI with positively charged surface.
Biosensors 12 00419 sch001
Figure 1. Representative TEM image of (a) HAP and (b) HAP−HE@PEI; (c) surface charge of HAP, HAP−HE and HAP−HE@PEI.
Figure 1. Representative TEM image of (a) HAP and (b) HAP−HE@PEI; (c) surface charge of HAP, HAP−HE and HAP−HE@PEI.
Biosensors 12 00419 g001
Figure 2. XRD patterns of HAP, HAP−HE and HAP−HE@PEI.
Figure 2. XRD patterns of HAP, HAP−HE and HAP−HE@PEI.
Biosensors 12 00419 g002
Figure 3. XPS spectra of HAP, HAP−HE and HAP−HE@PEI. (a) Survey scan ranging from 0 to 1200 eV, the High-resolution spectra of (b) C1s, (c) N 1s, (d) O 1s, (e) P2p and (f) Ca2p.
Figure 3. XPS spectra of HAP, HAP−HE and HAP−HE@PEI. (a) Survey scan ranging from 0 to 1200 eV, the High-resolution spectra of (b) C1s, (c) N 1s, (d) O 1s, (e) P2p and (f) Ca2p.
Biosensors 12 00419 g003
Figure 4. Normalized FT−IR spectra of HAP, HAP−HE and HAP−HE@PEI.
Figure 4. Normalized FT−IR spectra of HAP, HAP−HE and HAP−HE@PEI.
Biosensors 12 00419 g004
Figure 5. TGA curves of HAP, HAP−HE and HAP−HE@PEI.
Figure 5. TGA curves of HAP, HAP−HE and HAP−HE@PEI.
Biosensors 12 00419 g005
Figure 6. Fluorescence and UV Properties of samples. (a) The fluorescence photos of all samples in the UV light box. The numbers 1 to 5 represent HAP, HAP−HE, HAP−HE@PEI, HAP−HE@PEI@DOX and DOX, respectively. (b) Fluorescence spectrum (excitation wavelength: 440 nm). (c) UV-Vis Spectrum.
Figure 6. Fluorescence and UV Properties of samples. (a) The fluorescence photos of all samples in the UV light box. The numbers 1 to 5 represent HAP, HAP−HE, HAP−HE@PEI, HAP−HE@PEI@DOX and DOX, respectively. (b) Fluorescence spectrum (excitation wavelength: 440 nm). (c) UV-Vis Spectrum.
Biosensors 12 00419 g006
Figure 7. Cytotoxicity assay of HAP−HE@PEI@DOX and free DOX. The cell viability of A549 cells co-incubated with serials of concentrations of HAP−HE@PEI@DOX or DOX.
Figure 7. Cytotoxicity assay of HAP−HE@PEI@DOX and free DOX. The cell viability of A549 cells co-incubated with serials of concentrations of HAP−HE@PEI@DOX or DOX.
Biosensors 12 00419 g007
Figure 8. The release behavior of HAP−HE@PEI@DOX to DOX at pH 7.2 and 5.4.
Figure 8. The release behavior of HAP−HE@PEI@DOX to DOX at pH 7.2 and 5.4.
Biosensors 12 00419 g008
Figure 9. High-content imaging of HAP−HE@PEI. (a) Fluorescence images of NIH-3T3 cells co-incubated with different concentrations (12.5, 25, 50, 100 μg/mL) of HAP-HE@PEI for 0.5 h detected by high-content imaging system. (b) Fluorescence intensity of HAP-HE@PEI and NIH-3T3 cells incubated with same concentration (100 μg/mL) at different times (0.5, 1, 3 h). Values shown are mean ± S.D., **** p < 0.0001, vs. Blank group. (c) Fluorescence intensity of HAP-HE@PEI and NIH-3T3 cells incubated with different concentrations (12.5, 25, 50, 100 μg/mL) at the same time (1 h) (HAP-HE@PEI: Ex = 440 nm, Em = 520 nm; Hoechst 33342 for nucleus: Ex = 346 nm, Em = 460 nm). Values shown are mean ± S.D., ** p < 0.01, *** p < 0.001, **** p < 0.0001, vs. 100 μg/mL group, scale bar = 100 μm.
Figure 9. High-content imaging of HAP−HE@PEI. (a) Fluorescence images of NIH-3T3 cells co-incubated with different concentrations (12.5, 25, 50, 100 μg/mL) of HAP-HE@PEI for 0.5 h detected by high-content imaging system. (b) Fluorescence intensity of HAP-HE@PEI and NIH-3T3 cells incubated with same concentration (100 μg/mL) at different times (0.5, 1, 3 h). Values shown are mean ± S.D., **** p < 0.0001, vs. Blank group. (c) Fluorescence intensity of HAP-HE@PEI and NIH-3T3 cells incubated with different concentrations (12.5, 25, 50, 100 μg/mL) at the same time (1 h) (HAP-HE@PEI: Ex = 440 nm, Em = 520 nm; Hoechst 33342 for nucleus: Ex = 346 nm, Em = 460 nm). Values shown are mean ± S.D., ** p < 0.01, *** p < 0.001, **** p < 0.0001, vs. 100 μg/mL group, scale bar = 100 μm.
Biosensors 12 00419 g009
Figure 10. Bioprinting ink preparation and printing for 3D cell imaging process. (a) the preparation process of bio-ink (GelMA hydrogel containing 0.02 wt% HAP-HE@PEI). (b) 3D cell imaging process including 3D inkjet printing, photocuring, and collection of fluorescent images. (RAW 264.7 cells were grown in bio-ink for 12 h. HAP-HE@PEI: Ex = 440 nm, Em = 520 nm. Scale bar is 50 μm).
Figure 10. Bioprinting ink preparation and printing for 3D cell imaging process. (a) the preparation process of bio-ink (GelMA hydrogel containing 0.02 wt% HAP-HE@PEI). (b) 3D cell imaging process including 3D inkjet printing, photocuring, and collection of fluorescent images. (RAW 264.7 cells were grown in bio-ink for 12 h. HAP-HE@PEI: Ex = 440 nm, Em = 520 nm. Scale bar is 50 μm).
Biosensors 12 00419 g010
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Wan, W.; Li, Z.; Wang, X.; Tian, F.; Yang, J. Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications. Biosensors 2022, 12, 419. https://doi.org/10.3390/bios12060419

AMA Style

Wan W, Li Z, Wang X, Tian F, Yang J. Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications. Biosensors. 2022; 12(6):419. https://doi.org/10.3390/bios12060419

Chicago/Turabian Style

Wan, Weimin, Ziqi Li, Xi Wang, Fei Tian, and Jian Yang. 2022. "Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications" Biosensors 12, no. 6: 419. https://doi.org/10.3390/bios12060419

APA Style

Wan, W., Li, Z., Wang, X., Tian, F., & Yang, J. (2022). Surface-Fabrication of Fluorescent Hydroxyapatite for Cancer Cell Imaging and Bio-Printing Applications. Biosensors, 12(6), 419. https://doi.org/10.3390/bios12060419

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop